| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.001 |